Key Takeaways for Dental Practice Sellers
- The dental practice sale process often spans 4–12 months from listing to close, with 1–3 years of preparation before going to market, and moves through five main phases from valuation through closing.
- Information asymmetry usually favors buyers, because DSOs and private equity firms negotiate deals every week while most dentists sell only once, so professional representation and real competitive tension can be critical to protecting value.
- Valuation can be the anchor that shapes everything downstream, and a CPA-led, diligence-grade EBITDA analysis with documented add-backs can help prevent re-trades and support the agreed price through due diligence.
- Deal structure in DSO transactions usually combines 60–80% cash at close with equity and earnout components, so sellers benefit from underwriting the buyer like an investment and negotiating clear, protective earnout terms.
- McLerran & Associates focuses solely on dental sell-side representation across both private-buyer and DSO paths and reports an 85–90% transaction rate with roughly $2 billion in closed volume over about 35 years.
Talk with a dental-only advisor about your transition timeline.
Typical Timeline to Sell a Dental Practice
The dental practice sale process typically runs about 4–12 months from listing to close, with private doctor-to-doctor sales often taking 4–8 months and DSO transactions 8–18 months, according to Windsor Drake’s dental practice valuation guidance. Preparation commonly adds 1–3 years before that. The post-close transition period for a private doctor-to-doctor sale often runs about 4–6 weeks, while sale agreements generally require the seller to remain 60–180 days post-closing, compared with a multi-year working agreement that is typical of a DSO affiliation. Each phase carries its own duration range:
- Preparation and financial cleanup: 1–3 years before going to market
- Valuation: A CPA-led, diligence-grade dental practice appraisal typically takes about 4 weeks from the time the appraiser receives the requested documentation, with formal accredited appraisals generally running 3–6 weeks
- Marketing and buyer outreach: 4–8 weeks for a structured process
- LOI negotiation: 2–4 weeks
- Due diligence through closing: 8–14 weeks, with buyer diligence commonly running 90–120 days inside an exclusivity window
Several variables can compress or extend the timeline. Practice size, specialty, buyer type, financing, and how clean the financials are on day one can all influence speed. A structured, competitive DSO bid process, such as the one McLerran & Associates runs, typically takes about 45–60 days and can generate around 10 offers. That structure often moves faster than a do-it-yourself attempt that waits on a single buyer. For a deeper look at transition timelines, see McLerran & Associates’ Ideal Timeline to Plan a Dental Practice Transition and Sale.
How Hard It Can Be to Sell a Dental Practice
The dental practice sale process can be fragile and may collapse at several points. Do-it-yourself sales close at roughly 15–20%, versus roughly 80% for a well-run brokered process, according to McLerran & Associates’ experience across roughly 2,000 completed transactions. Difficulty depends mainly on preparation and representation. Premier, Class A practices are in steep demand and practice-level valuation multiples have held steady around 5x to 9x over the past two years, which can give sellers a relatively steady planning baseline.
Deals often fall apart for specific, identifiable reasons:
- Buyer-set or back-of-the-napkin valuations that get challenged in due diligence
- Weak EBITDA (earnings before interest, taxes, depreciation, and amortization) documentation that cannot withstand scrutiny
- Lack of competitive tension when a seller talks to only one buyer
- Financing failures, particularly when the practice is mispriced relative to what a lender will underwrite
- Financial inconsistencies, landlord issues, staffing instability, and seller cold feet as common post-LOI failure points
McLerran & Associates reports that roughly 85–90% of its clients transact, versus an industry norm closer to 35–40%. That gap reflects a process built around diligence-grade valuation, competitive tension, and active advocacy through every phase.
Phase 1: Preparation for a Dental Practice Sale
Preparation for the dental practice sale process starts with assembling 3 or more years of financial statements and tax returns, cleaning up discretionary and personal expenses, documenting systems and staffing, and clarifying the owner’s “why” and overall goals. The California Dental Association advises sellers to assemble a support team, review accounts receivable, and determine their timeframe for notifying patients and contracted dental plans as part of the transition process.
The central decision point in preparation is buyer path. Practices generating roughly $1–1.5M in annual revenue commonly fit a private doctor-to-doctor sale. Practices at $1.5M and above are generally eligible for DSO or private equity affiliation. Owners in the $1.5–3M middle can often go either way and may benefit from a side-by-side comparison before committing.
Specialty shapes buyer demand and valuation across all paths. Certain specialties command higher multiples and remain the fastest-consolidating segments, while general dentistry still earns aggressive, near-all-time-high valuations. Lighter-demand specialties sit at the lower end of the range, which means the specialty mix of a practice can materially change the buyer pool it attracts. Practices where the selling doctor produces 90% or more of clinical revenue consistently see valuation reductions, so reducing owner dependency before going to market can be one of the highest-return preparation steps.
Owners who have not yet decided whether to sell can explore options through education. McLerran & Associates is a PACE-accredited continuing-education provider and hosts the McLerran M&A Summit (October 29–30, 2026), a dental-only event where attendees receive a complimentary practice valuation (a $2,500 value) and 4 CE credits.
Phase 2: Valuation and EBITDA Analysis
Valuation sets expectations for both seller and buyer. For doctor-to-doctor deals, value is typically expressed as a percentage of revenue or a multiple of net cash flow. For DSO and private equity deals, value is expressed as a multiple of EBITDA, with the owner’s compensation normalized to a market-rate replacement dentist cost before the multiple is applied.
EBITDA add-backs are the adjustments that convert reported profit into true economic earnings. Common add-backs include the owner’s above-market compensation, personal expenses run through the business such as vehicle or phone, family payroll, one-time costs such as extraordinary repairs or legal settlements, and other non-recurring items. Each proposed add-back must be substantiated, because family payroll, retirement funding, and vehicle or travel expenses are not automatically transferable value. Buyers verify every add-back during diligence. A CPA-led, diligence-grade analysis done up front can keep a deal from being re-traded later. As one re-trade scenario illustrates, a $300,000 EBITDA reduction at a 6x multiple translates to $1.8 million of price reduction.
A buyer-set or “free” valuation often becomes the anchor that quietly caps what the owner walks away with. McLerran & Associates builds a CPA-led EBITDA analysis with every add-back unpacked and documented before the deal goes to market, so the numbers can hold when buyers scrutinize them. The firm has evaluated more than 10,000 dental practices and, for owners weighing both paths, delivers a side-by-side valuation that quantifies worth in both the private-buyer and DSO markets. The track record of roughly 2,000 successful practice sales and about $2 billion in closed transaction volume across roughly 35 years reflects that discipline. For more on what happens after a valuation, see What Happens After a Dental Practice Valuation.
Request a comprehensive, CPA-led valuation of your dental practice.
Phase 3: Going to Market and Choosing Buyers
Once the valuation is documented, the next decision is who to bring to the table. Buyer selection is a decision point with process implications and can shape both structure and timeline. The main buyer types in the dental practice sale process each demand something different:
- Private individual dentist (doctor-to-doctor): Typically needs financing support and a clean transition. Two common structures exist. In a walk-away sale, the seller works back roughly 4–8 weeks and exits. In a partnership or vest-out, the seller sells approximately 50% now, with the partner buying the remainder over time.
- DSO or private equity-backed platform: Runs formal diligence, a quality-of-earnings review, and multi-year employment agreements. DSO offers typically lead with 60% to 80% of a deal’s value as cash at closing, with the remainder in equity or earnout.
- Internal successors or partners: Associates or existing partners who buy in over time, often with a combination of bank financing and seller-held notes.
Competitive tension often separates a good outcome from a great one. A seller who talks to only one DSO sees only one offer and has limited leverage. McLerran & Associates runs a structured, auction-like bid process, typically about 45–60 days and generating around 10 offers, among a vetted pool of well-qualified buyers, with poorly run DSOs blacklisted. Practices taken to market through a structured multiple-buyer solicitation process receive final sale values averaging 50% above initial unsolicited offers. McLerran & Associates clients typically receive around a 30% higher valuation than owners achieve selling on their own. For a full comparison of transition options, see Dental Practice Transition Options: Private Sale vs. DSO.
Phase 4: Letter of Intent and Deal Structure Details
The letter of intent (LOI) is a non-binding agreement that outlines the key terms of a deal before the formal purchase agreement is drafted. It covers valuation, cash at close, equity, earnout terms, and the working agreement. This stage is where the real economics of a dental practice sale are set, and many unrepresented sellers give up value here.
Deal structure in a DSO transaction typically combines three components:
- Cash at close: Commonly 60–80% of total deal value, per TUSK Practice Sales’ Q3 2026 Dental M&A Market Report.
- Equity: Up to approximately 40% of a DSO deal can be paid in equity rather than cash, according to McLerran & Associates. Equity held at the joint-venture level pays distributions and carries a higher floor but lower ceiling. Equity held at the holding-company level pays no distributions but carries a higher ceiling that can multiply over time.
- Earnout: Contingent payments tied to post-close performance targets, typically over 1–3 years. Earnout provisions should specify the performance metric, baseline, accounting rules, seller control over staffing and marketing, reporting rights, and dispute procedures.
Most dental practice sales are structured as asset purchases rather than stock purchases. In an asset sale, the purchase price is allocated across goodwill, equipment, patient records, and non-compete agreements, and each category carries different tax treatment. Much of a DSO deal can be treated at long-term capital gains rates rather than ordinary income, depending on how the transaction is structured and allocated. Dentists should consult their own tax advisors, since individual circumstances vary significantly. For a detailed overview of tax implications, see Dental Practice Transition Tax Implications Explained.
Earnout traps can be significant. Earnout metric definitions can allow a buyer to increase overhead allocation and reduce EBITDA, and employment termination clauses can allow “without cause” termination that forfeits earnouts. A good advisor typically flags these in the first review. Non-punitive earnout structures, such as pro-rata provisions that pay most of the earnout even on a near-miss or later start dates that account for integration, can protect the seller.
McLerran & Associates negotiates all aspects of the LOI on the owner’s behalf and produces multi-year, multi-structure financial forecasting and cash-flow modeling across 3-, 5-, 7-, and 10-year horizons. The modeling conservatively assumes one recapitalization in years five to seven so the owner can compare real after-tax proceeds side by side.
Have McLerran & Associates structure and negotiate your LOI.
Phase 5: Due Diligence, Quality-of-Earnings Defense, and Closing
After the LOI is signed and the structure is set, the buyer conducts formal due diligence. This is a comprehensive review of the practice’s financials, operations, legal standing, and clinical records. On DSO deals, this includes a quality-of-earnings (QoE) review, in which the buyer’s accounting team independently verifies the EBITDA and challenges every add-back. The quality-of-earnings review is the diligence workstream most likely to move price, because buyers strip add-backs that the paper trail cannot support.
This stage is where deals often fall apart or get re-traded. A weak valuation analysis tends to be challenged here, while a diligence-grade one is more likely to hold. Approximately 30% of dental deals fail during due diligence because of poor records and lack of preparation.
On DSO deals, McLerran & Associates provides quality-of-earnings defense. The firm defends the EBITDA it underwrote when the buyer’s QoE team pokes holes and reminds buyers that other vetted bidders are waiting if they attempt to re-trade the deal downward. On private deals, the firm helps assemble the right advisor team, supports the buyer’s financing, and serves as the buffer between parties. McLerran makes introductions to attorneys, lenders, and other specialists but does not act as the attorney. Integration planning, credentialing transfers, and patient communications are all critical-path items that must be managed through closing to avoid disruption to collections and goodwill.
Post-Sale Transition for Dental Practice Owners
Post-sale life depends heavily on buyer type and deal structure. On a private doctor-to-doctor walk-away sale, the seller typically works back only about 4–8 weeks before exiting. On a DSO deal, a minimum 5-year working agreement is typical, though a shorter work-back may be possible if the owner has already reduced chair time significantly.
A DSO-bound seller usually wears three hats simultaneously. As a seller, the focus is on maximizing cash at close, equity, and earnout terms. As a partner, the seller needs to understand what the DSO will and will not handle, from compliance, HR, payroll, and IT to deeper infrastructure and growth support. As an investor, the seller evaluates the DSO’s equity, because as much as approximately 40% of the deal can be in stock, which effectively means buying into the DSO. Evaluating which DSOs are well-backed, well-run, and have a track record of satisfied sellers can be as important as the headline price.
Finding the right fit, including a buyer who will protect staff, patients, and legacy, sits at the center of McLerran & Associates’ mandate. The firm steers clients toward partners with a track record of happy sellers and has blacklisted DSOs known for creating poor post-close environments.
Discuss post-sale goals with a McLerran & Associates advisor.
Common Pitfalls in the Dental Practice Sale Process
The following mistakes can be some of the most costly in the dental practice sale process:
- Accepting a buyer-set or “free” valuation as the anchor. A back-of-the-napkin number often becomes the ceiling on what the owner walks away with. A CPA-led, diligence-grade valuation done before going to market can prevent that cap.
- Talking to only one buyer. A single conversation usually means limited leverage. A structured, auction-like process among a vetted pool of buyers can create real competitive tension.
- Failing to document EBITDA add-backs. Unsupported add-backs often get stripped in diligence, which reduces price. Assembling a paper trail for every add-back before the deal goes out can protect value.
- Signing a punitive earnout. Earnout metrics controlled by the buyer can be structurally difficult to achieve. Negotiating pro-rata provisions, later start dates, and clear metric definitions can make the earnout more achievable.
- Skipping due diligence on the DSO’s financial backing. As much as approximately 40% of a deal can be in equity, so partnering with an undercapitalized DSO can put a large share of proceeds at risk. Underwriting the DSO like an investment can reduce that risk.
- Going it alone without an advocate. Do-it-yourself close rates run roughly 15–20%. Sell-side representation from a dental-specific advisor can help control the narrative around EBITDA and defend the agreed value through closing.
The table below compares how each representation path typically handles several factors that often influence whether a deal closes at the agreed price.
| Dimension | DIY / FSBO | Local Generalist Broker | McLerran & Associates |
|---|---|---|---|
| Dental specialization | None | Local only | Dental-only, national |
| Both sale paths | No | Usually one | Both private-buyer & DSO, ~50/50 |
| Valuation quality | Buyer-set | Basic | CPA-led, diligence-grade |
| Transaction rate | ~15–20% | Below average | ~85–90% |
Frequently Asked Questions
How Long Does the Dental Practice Sale Process Take?
As noted above, the process typically runs about 4–12 months from listing to close, with preparation often adding 1–3 years. A structured DSO bid process usually runs 45–60 days inside that window, and post-close work-back can range from a few weeks on a private sale to several years on a DSO affiliation.
How Hard Is It to Sell a Dental Practice?
The process can be demanding because several stages can cause a deal to stall or fail. Do-it-yourself sales close at roughly 15–20%, versus roughly 80% for a well-run brokered process, according to McLerran & Associates. The most common failure points include weak EBITDA documentation, lack of competitive tension, financing issues, and unmanaged buyer diligence. A dental-specific sell-side advisor who manages the story around profitability and supports the valuation through closing can materially improve the odds of success.
How Do You Value a Dental Practice for Sale?
Value is calculated by the method that fits the chosen path. For doctor-to-doctor deals, value is often expressed as a percentage of revenue or a multiple of net cash flow. For DSO and private equity deals, value is expressed as a multiple of EBITDA, with the owner’s compensation normalized to a market-rate replacement dentist cost before the multiple is applied. EBITDA add-backs, which adjust for discretionary, personal, and non-recurring expenses, convert reported profit into true economic earnings. A CPA-led, diligence-grade analysis with every add-back unpacked and documented can help prevent re-trades later.
Should I Sell to a Private Buyer or a DSO?
The answer depends on practice size, profitability, and personal goals. Smaller premier practices, roughly $1–1.5M in revenue, often fit a doctor-to-doctor sale. The largest practices, around $3M and above, tend to point toward the DSO path. Owners in the $1.5–3M middle can often go either way. Because McLerran & Associates works both markets in roughly equal measure, it can produce a side-by-side valuation that quantifies the practice’s worth in both the private-buyer and DSO markets so the owner can choose with more complete information.
Are DSO Deals All Cash, or Is There Stock Involved?
Most DSO deals combine cash, equity, and an earnout. DSO offers typically lead with 60% to 80% of a deal’s value as cash at closing, with the remainder in equity or earnout. Equity can be held at the joint-venture level, which pays distributions and carries a higher floor but lower ceiling, or at the holding-company level, which pays no distributions but carries a higher potential upside. As much as approximately 40% of a deal can be in equity, which is why many sellers evaluate the DSO’s profitability, growth trajectory, management team, and private equity backing before committing.
Do I Have to Keep Working After I Sell?
Most DSO deals require continued clinical work. A minimum 5-year working agreement is typical, though a shorter work-back may be possible if the owner has already reduced chair time. On a private doctor-to-doctor walk-away sale, the seller typically works back only about 4–8 weeks before exiting. The terms of the post-close employment agreement, including compensation structure, clinical responsibilities, and transition timeline, can materially affect total proceeds and usually deserve the same level of attention as purchase price.
Why Use McLerran & Associates Instead of a Local Broker?
A local broker who knows only one or two DSOs often provides limited market exposure and lighter valuation work. McLerran & Associates is dental-only, runs a full competitive process among a vetted national buyer pool, and reports a transaction rate of roughly 85–90%, versus an industry norm closer to 35–40%. The firm has evaluated more than 10,000 dental practices, completed roughly 2,000 successful sales, and closed about $2 billion in transaction volume across roughly 35 years. Because it runs both the private-buyer and DSO paths in roughly equal measure, owners can see a genuine side-by-side comparison rather than a recommendation shaped by a single preferred path.
Conclusion and Practical Next Steps
The dental practice sale process typically runs through five phases, from preparation and valuation through going to market, LOI and deal structure, and due diligence to closing, followed by a post-sale transition that varies by buyer type. Across all phases, valuation can serve as the anchor, and representation often determines whether that number holds.
Practical next steps for any owner considering a transition include reviewing financials, clarifying personal and financial goals, comparing the private-buyer and DSO paths side by side, and speaking with a dental-specific sell-side advisor before committing to any path or buyer. Starting that conversation earlier, ideally 1–3 years before a target sale date, can be one of the higher-return decisions available, since dental practice owners who begin transition planning later than 3 years before exit may forfeit an estimated 15 to 30 percent of achievable practice value.
McLerran & Associates is the nation’s largest dental-specific sell-side M&A advisory and brokerage firm and is one of the few running both transition paths in roughly equal measure. With roughly 2,000 successful practice sales, about $2 billion in closed transaction volume, more than 10,000 practices evaluated, and a transaction rate of roughly 85–90% versus an industry norm closer to 35–40%, the firm focuses on seeing transitions through to closing. For a full overview of the transition process, see Dental Practice Transition: A Phase-By-Phase Seller’s Guide.
Connect with McLerran & Associates about your practice transition plans.
